Beyond GLP-1 Weight Loss: Weight Regain, Long-Term Use, and Pharma Influence with Ragen Chastain (Part Two)

This is a free preview of a paid episode. To hear more, visit abbieattwoodwellness.substack.comThis is part two of my conversation with Ragen Chastain. We pick up with the question of what happens when people stop taking GLP-1 medications, and whether “taking them for life” is actually supported by the research.From there, Ragen takes us deeper into the research on weight regain, body composition changes, and the increasingly broad claims that GLP-1 medications can treat everything from cardiovascular disease to mental health concerns. We also talk about pharmaceutical influence on healthcare providers, what happens when doctors are working from incomplete or biased information, and how patients can advocate for themselves when / if their doctor presents a GLP-1 as the answer.This is a bonus episode for paid subscribers. To join us, upgrade here.And if you’re already a paid subscriber: thank you for making this possible. I genuinely mean that.In this episode, you’ll hear:* What the research actually tells us about weight regain after stopping GLP-1 medications* The idea that GLP-1 medications need to be taken for life* Weight regain, muscle loss, and changes in body composition* How researchers define “maintaining” weight loss and why those definitions matter* The way GLP-1 research is presented in headlines, abstracts, and public conversations* Claims that GLP-1 medications may benefit conditions beyond type 2 diabetes and weight loss* Why the dose being studied matters when we’re trying to understand health outcomes* How pharmaceutical companies influence healthcare providers through research, education, and financial relationships* The difference between a doctor being malicious and a doctor being misinformed* What happens when GLP-1 medications are presented as a solution to almost every health concern* How weight stigma can shape which treatments are offered to higher-weight patients* BMI-based denials of care and the way weight loss can become a prerequisite for receiving healthcare* Questions patients can ask when a provider recommends a GLP-1* How to advocate for weight-inclusive care, even when there is a power imbalance between doctors and patients* Why informed consent requires more than simply being told that a medication “works”* What Ragen hopes people take away from the larger conversation about weight, health, and healthcareRagen Chastain is a researcher, writer, speaker, and board-certified patient advocate who has spent more than 20 years examining the intersections of weight science, weight stigma, and healthcare. She brings a research- and statistics-informed perspective to a conversation that is often dominated by pharmaceutical marketing, influencer anecdotes, and very simplified claims about what these medications do.Find Ragen at weightandhealthcare.substack.com and on instagram at @ragenchastainSupport the show on Substack for bonus episodes, community engagement, and access to "Ask Abbie" at abbieattwoodwellness.substack.com/subscribeApply for Abbie’s Group Membership for live sessions every other week and a community of support from healing from diet culture:https://www.abbieattwoodwellness.com/circle-monthly-groupSocial media:Find the show on Instagram: @fullplate.podcastFind Abbie on Instagram: @abbieattwoodwellness